...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Corp (ZEC) held the shares issued to RVX shareholders in June 2013.

It's been thoroughly discussed a few times.

Try this and the linked RVXOldTimer note.

Share
New Message
Please login to post a reply